Humalog pen (insulin lispro) / Eli Lilly 
Welcome,         Profile    Billing    Logout  
 41 Diseases   18 Trials   18 Trials   2363 News 
30 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Humalog pen (insulin lispro) / Eli Lilly
2011-001509-28: Efficacy and mechanisms of a short course of intensified insulin treatment on remission or responsiveness to oral therapy in type 2 diabetes Efficacia e meccanismi di un trattamento insulinico intensivo di breve durata sulla remissione o risposta alla terapia orale del diabete di tipo 2

Ongoing
4
75
Europe
Solution for injection, Suspension for injection, Coated tablet, HUMALOG*BASAL 10PEN 3ML 100U/M, HUMALOG NPL=>HUMALOG BASAL, GLUCOPHAGE*30CPR RIV 500MG
AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, Eli Lilly S.p.A., Universita' di Pisa
Newly-diagnosed type 2 diabetes patients. Pazienti naive con diagnosi di diabete di tipo 2., Untreated patients with type 2 diabetes. Pazienti non trattati con diagnosi di diabete di tipo 2., Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2005-004048-30: Raskausdiabeteksen lääkehoito

Ongoing
4
278
Europe
Diformin retard, Protaphane Flexpen, Novorapid Flexpen, Humalog Pen, Diformin retard, Protaphane Flexpen, Novorapid Flexpen, Humalog Pen
Turku Univeristy Hospital
Raskausdiabetes
 
 
2005-005914-18: Effect of Insulin Glulisin on postprandial plasma glucose levels in obese subjectts with type 2 diabetes after a standard meal in comparison to Insulin Lispro

Ongoing
4
30
Europe
Apidra, Humalog, Apidra, Humalog, Apidra, Humalog
Diabetes-Centre Quakenbrueck
Obese subjects with type 2 diabetes mellitus
 
 
2007-005212-41: ESTUDIO COMPARATIVO DEL TRATAMIENTO CON BOMBA DE INSULINA SUBCUTANEA, INSULINA GLARGINA E INSULINA NPH EN NIÑOS DIABÉTICOS DE 0 A 6 AÑOS DE EDADComparative study between treatment with insulin pump, insulin gragina and insulin NPH in diabetic children from 0 to 6 years old.

Ongoing
4
30
Europe
LANTUS, HUMULINA NPH, HUMALOG, LANTUS, HUMULINA NPH, HUMALOG
HOSPITAL SANT JOAN DE DÉU
ESTUDIO COMPARATIVO DEL TRATAMIENTO CON BOMBA DE INSULINA SUBCUTANEA, INSULINA GLARGINA E INSULINA NPH EN NIÑOS DIABÉTICOS DE 0 A 6 AÑOS DE EDAD.Comparative study between treatment with insulin pump, insulin gragina and insulin NPH in diabetic children from 0 to 6 years old.
 
 
2012-000216-28: Intensive Insulin Protocol in Renal Transplant Recipients Receiving a Tacrolimus-based Immunosuppression

Ongoing
4
50
Europe
Humalog, Humalog
Medizinische Universität Wien, Universitätsklinik für Innere Medizin III, Österreichische Diabetes Gesellschaft (ÖDG)
New onset diabetes after organ-transplantation
 
 
NCT04124302: The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

Not yet recruiting
4
70
NA
Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog
Medical University of Warsaw
Diabetes Mellitus, Type 1
08/21
08/23
NCT04019821: Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

Completed
4
72
Europe
Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog
Medical University of Warsaw
Diabetes Mellitus, Type 1
01/23
04/23
SITAGLAR-H, NCT05579119: SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting

Completed
4
76
RoW
Sitagliptin 100mg, Januvia, Glargine, Lantus, Lispro, Humalog
Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social, National Polytechnic Institute, Mexico
Type 2 Diabetes
08/23
08/23
NCT04416269: Oral Anti Diabetic Agents in the Hospital

Recruiting
4
260
US
Oral Anti-diabetes Drugs alone, metformin, sulfonylureas, pioglitazone, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors, Basal bolus insulin, glargine, detemir, Supplemental insulin, Humalog, Novolog, Continuous glucose monitoring (CGM), Dexcom
Emory University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus
07/25
07/25
2010-022246-25: Diagnostic clinique et mécanismes physiopathologiques de l'allergie à l'insuline.

Not yet recruiting
3
70
Europe
Actrapid, Insulatard, Insuman Infusat, Humalog, NovoRapid, Apidra, Lantus, Levemir, Latex, Solution for injection, Suspension for injection, Solution for infusion, Actrapid, Insulatard, Novorapid, Levemir
Allergie à l'insuline
 
 
2016-001401-16: The SUGAR-DIP trial: Oral medication versus insulin for diabetes in pregnancy De SUGAR-DIP trial: Orale medicatie versus insuline voor zwangerschapsdiabetes

Ongoing
3
810
Europe
Metformin, Glibenclamide, Tablet, Injection, Metformin, Glibenclamide, Insulin: including - fast acting, analog: NovoRapid, Humalog, Apidra - short acting, human: Actrapid, Humuline Regular, Insuman Rapid - medium long acting, human: Insulatard, Humuline NPH, Insuman Basal - long acting analog: Lantus, Levemir
University Medical Center Utrecht, ZonMw
The medical condition to be investigated in this trial is gestational diabetes with insufficient glycemic control by means of dietary adjustments and thus an indication for addiotional pharmacological treatment. In deze trial wordt het ziektebeeld diabetes gravidarum onderzocht, waarbij er met dieetaanpassingen onvoldoende glucosecontrole is bereikt en er dus indicatie is voor aanvullende farmacologische behandeling., Gestational diabetes, also known as gestational diabetes mellitus, is a condition in which women without previously diagnosed diabetes exhibit high blood glucose (blood sugar) levels during pregnancy. Zwangerschapssuikerziekte, ook wel zwangerschapsdiabetes, is een aandoening waarbij vrouwen waarbij niet al eerder suikerziekte is vastgesteld, tijdens de zwangerschap hoge bloedsuikerwaardes hebben., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
2017-001657-13: A Clinical Trial to see how your body responds to the Gan & Lee Insulin Lispro Injection and how safe it is as compared to the Humalog® (Insulin Lispro Injection) in Adults with Type 1 Diabetes Mellitus Un ensayo clínico para ver cómo responde su cuerpo a la inyección de insulina lispro de Gan & Lee y lo seguro que es en comparación con Humalog® (inyección de insulina lispro) en sujetos adultos con diabetes mellitus de tipo 1

Not yet recruiting
3
550
Europe
Gan & Lee Insulin Lispro Injection, HUMALOG® (INSULIN LISPRO INJECTION), Gan & Lee Insulin Lispro Injection, HUMALOG®, Solution for injection in pre-filled pen, Humalog®
Gan & Lee Pharmaceuticals USA Corporation, Gan & Lee Pharmaceuticals USA Corporation
Type 1 diabetes mellitus Diabetes mellitus de tipo 1, Type 1 diabetes mellitus Diabetes mellitus de tipo 1, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
INHALE-1, NCT04974528: Afrezza® Study in Pediatrics

Completed
3
319
US
Afrezza, Technosphere Insulin, Rapid-acting Insulin Analog, insulin aspart, insulin lispro, insulin glulisine, Novolog®, Fiasp®, Humalog®, Admelog®, Apidra®, Basal Insulin, insulin glargine, insulin degludec, insulin detemir, Lantus®, Abasaglar®, Basaglar®, Semglee®, Toujeo®, Tresiba®, Levemir®
Mannkind Corporation, Jaeb Center for Health Research
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
10/24
04/25
QWINT-4, NCT05462756 / 2021-005878-25: A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

Completed
3
730
Europe, US, RoW
Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Lispro (U100), Humalog, Insulin Glargine (U100), Basaglar
Eli Lilly and Company, Eli Lilly and Company
Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
02/24
02/24
2016-003126-16: Measurement of the effect of Canagliflozin versus Placebo in type 2 diabetes during insulin-mediated hypoglycemia Valutazione dell¿effetto di canagliflozin in confronto a placebo in pazienti con diabete di tipo 2 durante l¿ipoglicemia indotta dall¿insulina

Not yet recruiting
2
12
Europe
INVOKANA, HUMALOG, INVOKANA, HUMALOG, Capsule, hard, Solution for injection, INVOKANA - 300 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE BLISTER (PVC/ALU) - 30 COMPRESSE, HUMALOG - 100 U/ML SOLUZIONE INIETTABILE 1 FLACONE 10 ML
AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, Janssen-Cilag, Dip. Univ. Medicina clinica e sperimentale Pisa
Type 2 diabetes Diabete tipo 2, Type 2 diabetes Diabete tipo 2, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2015-003737-95: A Study to Investigate Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Subjects with Type 1 Diabetes Mellitus (T1DM)

Ongoing
2
12
Europe
Dance 501 Human Insulin Inhalation Solution, Nebuliser solution, Solution for injection, Humalog
Dance Biopharm Inc., Dance Biopharm Inc.
Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2015-003672-76: A Study to Investigate the Dose Response of Dance 501 in Subjects with Type 1 Diabetes Mellitus (T1DM)

Ongoing
2
24
Europe
Dance 501 Human Insulin Inhalation Solution, Nebuliser solution, Solution for injection, Humalog
Dance Biopharm Inc., Dance Biopharm Inc.
Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2019-002318-37: A study in Type I Diabetes Mellitus

Not yet recruiting
1/2
20
Europe
LY900027, Humalog, LY900027, A10AB04, Solution for injection, Humalog
Eli Lilly and Company Limited, Eli Lilly and Company
Type I Diabetes Mellitus, Type 1 Diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
NCT05373199: A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes

Completed
1
30
Europe
Euglycemic clamp with BC Combo THDB0207, Euglycemic clamp with Lantus®, Euglycemic clamp with Humalog®
Adocia, Tonghua Dongbao Pharmaceutical Co.,Ltd
Type 1 Diabetes
10/22
10/22
NCT05262387: A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

Completed
1
25
Canada
Lyumjev with 50% basal rate reduction, LY900014, Humalog with 50% basal rate reduction, Insulin Lispro, Humalog with 100% basal rate reduction, Lyumjev with 100% basal rate reduction
Eli Lilly and Company
Diabetes Mellitus, Type 1
03/23
03/23
FAST 1, NCT05508061 / 2022-001373-31: Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

Completed
N/A
12
Europe
Insulin Lispro Cartridge [Lyumjev], Lyumjev, Insulin Lispro Cartridge, Humalog
Inreda Diabetic B.V., Inreda Diabetic B.V.
Type 1 Diabetes
03/23
03/23
NCT05571878: Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents

Active, not recruiting
N/A
24
Canada
Humalog, Intranasal Insulin, Saline nasal spray, Intranasal Placebo
Centre for Addiction and Mental Health
Major Depressive Disorder, Depression
05/25
05/25
NCT04965051: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

Recruiting
N/A
40
RoW
insulin degludec/insulin aspart (IDegAsp), Ryzodeg, basal insulin plus pre-prandial insulin, Levemir/Lantus/Tresiba plus NovoLog/Humalog/Apidra
Second Affiliated Hospital, School of Medicine, Zhejiang University
Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range
12/23
12/23
ACOLYTE, NCT05660941: Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro ( Study)

Recruiting
N/A
26
Europe
Lispro, Lyumjev, Humalog
Manchester University NHS Foundation Trust
Diabetes Mellitus, Type 1
05/24
05/24
NCT05893797: A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

Completed
N/A
36
Europe
Insulin Lispro, Humalog Tempo Pen, Tempo Smart Button, Dexcom G6 CGM, Glooko Research Medical App (RMA)
Eli Lilly and Company
Type 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
09/24
09/24
NCT06532461: A Trial of Three- and Seven-days Insulin Infusions Set

Recruiting
N/A
80
Europe
Mio Advanced infusions set, Extended wear insulin infusions (EWIS), Novorapid, Humalog, Extended wear insulin infusion (EWIS)
Steno Diabetes Center Copenhagen
Type 1 Diabetes
12/26
12/26
START2, NCT06419803: Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)

Recruiting
N/A
430
US
Insulin, Lantus, Lispro, NPH, Levemir, Humalog
Thomas Jefferson University, University of Rochester
Gestational Diabetes, Pregnancy Related
05/26
05/26
START 1, NCT06419777: Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

Recruiting
N/A
430
US
Insulin, Lantus, Lispro, NPH, Levemir, Humalog
Thomas Jefferson University, University of Rochester
Gestational Diabetes, Pregnancy Related
05/26
05/26
NCT05748990: Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Recruiting
N/A
20
Canada
Intranasal insulin, Humalog, Placebo, saline
Centre for Addiction and Mental Health
Schizophrenia, Healthy
04/25
04/25
NCT06948760: Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

Not yet recruiting
N/A
20
US
Control-IQ insulin pump with Lyumjev insulin, Experimental Group, Control-IQ insulin pump with Humalog or Novolog, Control Group
Mark D. DeBoer, MD, MSc., MCR, University of Virginia
Type 1 Diabetes
03/26
03/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Humalog pen (insulin lispro) / Eli Lilly
2011-001509-28: Efficacy and mechanisms of a short course of intensified insulin treatment on remission or responsiveness to oral therapy in type 2 diabetes Efficacia e meccanismi di un trattamento insulinico intensivo di breve durata sulla remissione o risposta alla terapia orale del diabete di tipo 2

Ongoing
4
75
Europe
Solution for injection, Suspension for injection, Coated tablet, HUMALOG*BASAL 10PEN 3ML 100U/M, HUMALOG NPL=>HUMALOG BASAL, GLUCOPHAGE*30CPR RIV 500MG
AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, Eli Lilly S.p.A., Universita' di Pisa
Newly-diagnosed type 2 diabetes patients. Pazienti naive con diagnosi di diabete di tipo 2., Untreated patients with type 2 diabetes. Pazienti non trattati con diagnosi di diabete di tipo 2., Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2005-004048-30: Raskausdiabeteksen lääkehoito

Ongoing
4
278
Europe
Diformin retard, Protaphane Flexpen, Novorapid Flexpen, Humalog Pen, Diformin retard, Protaphane Flexpen, Novorapid Flexpen, Humalog Pen
Turku Univeristy Hospital
Raskausdiabetes
 
 
2005-005914-18: Effect of Insulin Glulisin on postprandial plasma glucose levels in obese subjectts with type 2 diabetes after a standard meal in comparison to Insulin Lispro

Ongoing
4
30
Europe
Apidra, Humalog, Apidra, Humalog, Apidra, Humalog
Diabetes-Centre Quakenbrueck
Obese subjects with type 2 diabetes mellitus
 
 
2007-005212-41: ESTUDIO COMPARATIVO DEL TRATAMIENTO CON BOMBA DE INSULINA SUBCUTANEA, INSULINA GLARGINA E INSULINA NPH EN NIÑOS DIABÉTICOS DE 0 A 6 AÑOS DE EDADComparative study between treatment with insulin pump, insulin gragina and insulin NPH in diabetic children from 0 to 6 years old.

Ongoing
4
30
Europe
LANTUS, HUMULINA NPH, HUMALOG, LANTUS, HUMULINA NPH, HUMALOG
HOSPITAL SANT JOAN DE DÉU
ESTUDIO COMPARATIVO DEL TRATAMIENTO CON BOMBA DE INSULINA SUBCUTANEA, INSULINA GLARGINA E INSULINA NPH EN NIÑOS DIABÉTICOS DE 0 A 6 AÑOS DE EDAD.Comparative study between treatment with insulin pump, insulin gragina and insulin NPH in diabetic children from 0 to 6 years old.
 
 
2012-000216-28: Intensive Insulin Protocol in Renal Transplant Recipients Receiving a Tacrolimus-based Immunosuppression

Ongoing
4
50
Europe
Humalog, Humalog
Medizinische Universität Wien, Universitätsklinik für Innere Medizin III, Österreichische Diabetes Gesellschaft (ÖDG)
New onset diabetes after organ-transplantation
 
 
NCT04124302: The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

Not yet recruiting
4
70
NA
Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog
Medical University of Warsaw
Diabetes Mellitus, Type 1
08/21
08/23
NCT04019821: Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

Completed
4
72
Europe
Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog
Medical University of Warsaw
Diabetes Mellitus, Type 1
01/23
04/23
SITAGLAR-H, NCT05579119: SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting

Completed
4
76
RoW
Sitagliptin 100mg, Januvia, Glargine, Lantus, Lispro, Humalog
Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social, National Polytechnic Institute, Mexico
Type 2 Diabetes
08/23
08/23
NCT04416269: Oral Anti Diabetic Agents in the Hospital

Recruiting
4
260
US
Oral Anti-diabetes Drugs alone, metformin, sulfonylureas, pioglitazone, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors, Basal bolus insulin, glargine, detemir, Supplemental insulin, Humalog, Novolog, Continuous glucose monitoring (CGM), Dexcom
Emory University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus
07/25
07/25
2010-022246-25: Diagnostic clinique et mécanismes physiopathologiques de l'allergie à l'insuline.

Not yet recruiting
3
70
Europe
Actrapid, Insulatard, Insuman Infusat, Humalog, NovoRapid, Apidra, Lantus, Levemir, Latex, Solution for injection, Suspension for injection, Solution for infusion, Actrapid, Insulatard, Novorapid, Levemir
Allergie à l'insuline
 
 
2016-001401-16: The SUGAR-DIP trial: Oral medication versus insulin for diabetes in pregnancy De SUGAR-DIP trial: Orale medicatie versus insuline voor zwangerschapsdiabetes

Ongoing
3
810
Europe
Metformin, Glibenclamide, Tablet, Injection, Metformin, Glibenclamide, Insulin: including - fast acting, analog: NovoRapid, Humalog, Apidra - short acting, human: Actrapid, Humuline Regular, Insuman Rapid - medium long acting, human: Insulatard, Humuline NPH, Insuman Basal - long acting analog: Lantus, Levemir
University Medical Center Utrecht, ZonMw
The medical condition to be investigated in this trial is gestational diabetes with insufficient glycemic control by means of dietary adjustments and thus an indication for addiotional pharmacological treatment. In deze trial wordt het ziektebeeld diabetes gravidarum onderzocht, waarbij er met dieetaanpassingen onvoldoende glucosecontrole is bereikt en er dus indicatie is voor aanvullende farmacologische behandeling., Gestational diabetes, also known as gestational diabetes mellitus, is a condition in which women without previously diagnosed diabetes exhibit high blood glucose (blood sugar) levels during pregnancy. Zwangerschapssuikerziekte, ook wel zwangerschapsdiabetes, is een aandoening waarbij vrouwen waarbij niet al eerder suikerziekte is vastgesteld, tijdens de zwangerschap hoge bloedsuikerwaardes hebben., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
2017-001657-13: A Clinical Trial to see how your body responds to the Gan & Lee Insulin Lispro Injection and how safe it is as compared to the Humalog® (Insulin Lispro Injection) in Adults with Type 1 Diabetes Mellitus Un ensayo clínico para ver cómo responde su cuerpo a la inyección de insulina lispro de Gan & Lee y lo seguro que es en comparación con Humalog® (inyección de insulina lispro) en sujetos adultos con diabetes mellitus de tipo 1

Not yet recruiting
3
550
Europe
Gan & Lee Insulin Lispro Injection, HUMALOG® (INSULIN LISPRO INJECTION), Gan & Lee Insulin Lispro Injection, HUMALOG®, Solution for injection in pre-filled pen, Humalog®
Gan & Lee Pharmaceuticals USA Corporation, Gan & Lee Pharmaceuticals USA Corporation
Type 1 diabetes mellitus Diabetes mellitus de tipo 1, Type 1 diabetes mellitus Diabetes mellitus de tipo 1, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
INHALE-1, NCT04974528: Afrezza® Study in Pediatrics

Completed
3
319
US
Afrezza, Technosphere Insulin, Rapid-acting Insulin Analog, insulin aspart, insulin lispro, insulin glulisine, Novolog®, Fiasp®, Humalog®, Admelog®, Apidra®, Basal Insulin, insulin glargine, insulin degludec, insulin detemir, Lantus®, Abasaglar®, Basaglar®, Semglee®, Toujeo®, Tresiba®, Levemir®
Mannkind Corporation, Jaeb Center for Health Research
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
10/24
04/25
QWINT-4, NCT05462756 / 2021-005878-25: A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

Completed
3
730
Europe, US, RoW
Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Lispro (U100), Humalog, Insulin Glargine (U100), Basaglar
Eli Lilly and Company, Eli Lilly and Company
Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
02/24
02/24
2016-003126-16: Measurement of the effect of Canagliflozin versus Placebo in type 2 diabetes during insulin-mediated hypoglycemia Valutazione dell¿effetto di canagliflozin in confronto a placebo in pazienti con diabete di tipo 2 durante l¿ipoglicemia indotta dall¿insulina

Not yet recruiting
2
12
Europe
INVOKANA, HUMALOG, INVOKANA, HUMALOG, Capsule, hard, Solution for injection, INVOKANA - 300 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE BLISTER (PVC/ALU) - 30 COMPRESSE, HUMALOG - 100 U/ML SOLUZIONE INIETTABILE 1 FLACONE 10 ML
AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, Janssen-Cilag, Dip. Univ. Medicina clinica e sperimentale Pisa
Type 2 diabetes Diabete tipo 2, Type 2 diabetes Diabete tipo 2, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2015-003737-95: A Study to Investigate Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Subjects with Type 1 Diabetes Mellitus (T1DM)

Ongoing
2
12
Europe
Dance 501 Human Insulin Inhalation Solution, Nebuliser solution, Solution for injection, Humalog
Dance Biopharm Inc., Dance Biopharm Inc.
Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2015-003672-76: A Study to Investigate the Dose Response of Dance 501 in Subjects with Type 1 Diabetes Mellitus (T1DM)

Ongoing
2
24
Europe
Dance 501 Human Insulin Inhalation Solution, Nebuliser solution, Solution for injection, Humalog
Dance Biopharm Inc., Dance Biopharm Inc.
Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2019-002318-37: A study in Type I Diabetes Mellitus

Not yet recruiting
1/2
20
Europe
LY900027, Humalog, LY900027, A10AB04, Solution for injection, Humalog
Eli Lilly and Company Limited, Eli Lilly and Company
Type I Diabetes Mellitus, Type 1 Diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
NCT05373199: A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes

Completed
1
30
Europe
Euglycemic clamp with BC Combo THDB0207, Euglycemic clamp with Lantus®, Euglycemic clamp with Humalog®
Adocia, Tonghua Dongbao Pharmaceutical Co.,Ltd
Type 1 Diabetes
10/22
10/22
NCT05262387: A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

Completed
1
25
Canada
Lyumjev with 50% basal rate reduction, LY900014, Humalog with 50% basal rate reduction, Insulin Lispro, Humalog with 100% basal rate reduction, Lyumjev with 100% basal rate reduction
Eli Lilly and Company
Diabetes Mellitus, Type 1
03/23
03/23
FAST 1, NCT05508061 / 2022-001373-31: Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

Completed
N/A
12
Europe
Insulin Lispro Cartridge [Lyumjev], Lyumjev, Insulin Lispro Cartridge, Humalog
Inreda Diabetic B.V., Inreda Diabetic B.V.
Type 1 Diabetes
03/23
03/23
NCT05571878: Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents

Active, not recruiting
N/A
24
Canada
Humalog, Intranasal Insulin, Saline nasal spray, Intranasal Placebo
Centre for Addiction and Mental Health
Major Depressive Disorder, Depression
05/25
05/25
NCT04965051: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

Recruiting
N/A
40
RoW
insulin degludec/insulin aspart (IDegAsp), Ryzodeg, basal insulin plus pre-prandial insulin, Levemir/Lantus/Tresiba plus NovoLog/Humalog/Apidra
Second Affiliated Hospital, School of Medicine, Zhejiang University
Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range
12/23
12/23
ACOLYTE, NCT05660941: Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro ( Study)

Recruiting
N/A
26
Europe
Lispro, Lyumjev, Humalog
Manchester University NHS Foundation Trust
Diabetes Mellitus, Type 1
05/24
05/24
NCT05893797: A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

Completed
N/A
36
Europe
Insulin Lispro, Humalog Tempo Pen, Tempo Smart Button, Dexcom G6 CGM, Glooko Research Medical App (RMA)
Eli Lilly and Company
Type 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Treated With Insulin
09/24
09/24
NCT06532461: A Trial of Three- and Seven-days Insulin Infusions Set

Recruiting
N/A
80
Europe
Mio Advanced infusions set, Extended wear insulin infusions (EWIS), Novorapid, Humalog, Extended wear insulin infusion (EWIS)
Steno Diabetes Center Copenhagen
Type 1 Diabetes
12/26
12/26
START2, NCT06419803: Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)

Recruiting
N/A
430
US
Insulin, Lantus, Lispro, NPH, Levemir, Humalog
Thomas Jefferson University, University of Rochester
Gestational Diabetes, Pregnancy Related
05/26
05/26
START 1, NCT06419777: Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

Recruiting
N/A
430
US
Insulin, Lantus, Lispro, NPH, Levemir, Humalog
Thomas Jefferson University, University of Rochester
Gestational Diabetes, Pregnancy Related
05/26
05/26
NCT05748990: Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Recruiting
N/A
20
Canada
Intranasal insulin, Humalog, Placebo, saline
Centre for Addiction and Mental Health
Schizophrenia, Healthy
04/25
04/25
NCT06948760: Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

Not yet recruiting
N/A
20
US
Control-IQ insulin pump with Lyumjev insulin, Experimental Group, Control-IQ insulin pump with Humalog or Novolog, Control Group
Mark D. DeBoer, MD, MSc., MCR, University of Virginia
Type 1 Diabetes
03/26
03/26

Download Options